Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions clinical trial (NCT03947385). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of IDE196 and how do they compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions clinical trial (NCT03947385). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions clinical trial (NCT03947385). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the treatment cycles?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions clinical trial (NCT03947385). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific tests or procedures I will need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions clinical trial (NCT03947385). Contact the study team or your healthcare provider for specific answers.

Question 6

How does this trial fit into my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions clinical trial (NCT03947385). Contact the study team or your healthcare provider for specific answers.

What this study is about